The enhancer landscape predetermines the skeletal regeneration capacity of stromal cells
Science Translational Medicine · 2023
DOI: 10.1126/scitranslmed.abm7477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2023. Verfasst von Sarah Hochmann und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), 5020 Salzburg, A…. Hauptthemen laut MEDLINE: Stromal Cells, Cartilage. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Multipotent stromal cells are considered attractive sources for cell therapy and tissue engineering. Despite numerous experimental and clinical studies, broad application of stromal cell therapeutics is not yet emerging. A major challenge is the functional diversity of available cell sources. Here, we investigated the regenerative potential of clinically relevant human stromal cells from bone marrow (BMSCs), white adipose tissue, and umbilical cord compared with mature chondrocytes and skin fibroblasts in vitro and in vivo. Although all stromal cell types could express transcription factors related to endochondral ossification, only BMSCs formed cartilage discs in vitro that fully regenerated critical-size femoral defects after transplantation into mice. We identified cell type–specific epigenetic landscapes as the underlying molecular mechanism controlling transcriptional stromal differentiation networks. Binding sites of commonly expressed transcription factors in the enhancer and promoter regions of ossification-related genes, including Runt and bZIP families, were accessible only in BMSCs but not in extraskeletal stromal cells. This suggests an epigenetically predetermined differentiation potential depending on cell origin that allows common transcription factors to trigger distinct organ-specific transcriptional programs, facilitating forward selection of regeneration-competent cell sources. Last, we demonstrate that viable human BMSCs initiated defect healing through the secretion of osteopontin and contributed to transient mineralized bone hard callus formation after transplantation into immunodeficient mice, which was eventually replaced by murine recipient bone during final tissue remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), 5020 Salzburg, Austria.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), T Cell Epigenetics, Augustenburger Platz 1, 13353 Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Augustenburger Platz 1, 13353 Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Julius Wolff Institute (JWI), Augustenburger Platz 1, 13353 Berlin, Germany.
- Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
ORCID-Profile: Sarah Hochmann, Kristy Ou, Rodolphe Poupardin, Salaheddine Ali, Martin Wolf, Agnes Ellinghaus, Dorit Jacobi, Samantha Donsante, Mara Riminucci, Richard Schäfer, Uwe Kornak, Oliver Klein, Katharina Schallmoser, Katharina Schmidt-Bleek, Georg N Duda, Julia K Polansky, Sven Geissler, Dirk Strunk
Zitieren
APA
Hochmann, S., Ou, K., Poupardin, R., Mittermeir, M., Textor, M., Ali, S., Wolf, M., Ellinghaus, A., Jacobi, D., Elmiger, J. A. J., Donsante, S., Riminucci, M., Schäfer, R., Kornak, U., Klein, O., Schallmoser, K., Schmidt-Bleek, K., Duda, G. N., Polansky, J. K., …, & Strunk, D. (2023). The enhancer landscape predetermines the skeletal regeneration capacity of stromal cells. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abm7477
Vancouver
Hochmann S, Ou K, Poupardin R, Mittermeir M, Textor M, Ali S, et al. The enhancer landscape predetermines the skeletal regeneration capacity of stromal cells. Science Translational Medicine. 2023. doi:10.1126/scitranslmed.abm7477
BibTeX
@article{Hochmann2023,
author = {Hochmann, Sarah and Ou, Kristy and Poupardin, Rodolphe and Mittermeir, Michaela and Textor, Martin and Ali, Salaheddine and Wolf, Martin and Ellinghaus, Agnes and Jacobi, Dorit and Elmiger, Juri A J and Donsante, Samantha and Riminucci, Mara and Schäfer, Richard and Kornak, Uwe and Klein, Oliver and Schallmoser, Katharina and Schmidt-Bleek, Katharina and Duda, Georg N and Polansky, Julia K and Geissler, Sven and Strunk, Dirk},
title = {The enhancer landscape predetermines the skeletal regeneration capacity of stromal cells},
journal = {Science Translational Medicine},
year = {2023},
doi = {10.1126/scitranslmed.abm7477}
}
EUVIMED